mortality/aging
• mice exhibit increased mortality after 6 months and no mice survives beyond 22 months
|
reproductive system
• mice exhibit hemorrhage into the ovarian follicles
|
• female mice mated to wild-type mice exhibit reduced litter size compared to wild-type female mice
|
hematopoietic system
• after 5 months
|
• beyond 5 months of age, mice exhibit immature and maturing mononuclear cells in the peripheral blood unlike wild-type mice
|
• increased in the spleen and bone marrow
|
• after 5 months, mice exhibit extramedullary hematopoiesis in the liver and spleen
• after 5 months, mice exhibit increased erythropoiesis in the spleen
|
• at 2 to 5 months of age, mice exhibit mild anemia that becomes severe beyond 5 months of age
|
• in mice older than 5 months
|
• the bone marrow of mice with symptoms of chronic myelomonocytic leukemia (CMML)
|
• in the spleens of mice with symptoms of chronic myelomonocytic leukemia (CMML)
|
• in mice older than 5 months
|
• at 2 to 5 months of age, mice exhibit a progressive loss of platelets that becomes severe beyond 5 months of age
|
• at 2 to 5 months of age, mice exhibit mild leukopenia
|
• at 2 to 5 months of age
|
• at 2 to 5 months of age
|
• the bone marrow of mice with symptoms of chronic myelomonocytic leukemia (CMML)
|
• in the spleen of mice with symptoms of chronic myelomonocytic leukemia (CMML)
|
• beyond 5 months of age
|
• spleens mice with symptoms of chronic myelomonocytic leukemia (CMML)
• 12% of mice develop acute myeloid leukemia with a rapid increase in white blood cell count between 12 and 22 months
|
• the bone marrow of mice with symptoms of chronic myelomonocytic leukemia (CMML)
|
• in the bone marrow and spleen
|
endocrine/exocrine glands
• mice exhibit hemorrhage into the ovarian follicles
|
liver/biliary system
• after 5 months
|
neoplasm
• mice exhibit chronic myelomonocytic leukemia (CMML) symptoms
• 12% of mice develop acute myeloid leukemia with a rapid increase in white blood cell count between 12 and 22 months
|
• mice with acute myeloid leukemia (AML) also develop myeloid sarcomas in spleens and livers
|
skeleton
• sick mice exhibit bone marrow with reticulin fibrosis and increased apoptosis compared to wild type mice
• hematopoietic stem cell populations are expanded in the bone marrow compared to in wild-type mice
• the bone marrow of mice with symptoms of chronic myelomonocytic leukemia (CMML) exhibits an increase in T cells and a decreased in erythrocytes and B cells compared to in wild-type mice
|
• sick mice exhibit bone marrow with reticulin fibrosis
|
respiratory system
• in mice older than 5 months
|
cardiovascular system
• mice exhibit hemorrhage into the ovarian follicles
|
behavior/neurological
• in mice older than 5 months
|
immune system
• beyond 5 months of age, mice exhibit immature and maturing mononuclear cells in the peripheral blood unlike wild-type mice
|
• after 5 months
|
• at 2 to 5 months of age, mice exhibit mild leukopenia
|
• at 2 to 5 months of age
|
• at 2 to 5 months of age
|
• the bone marrow of mice with symptoms of chronic myelomonocytic leukemia (CMML)
|
• in the spleen of mice with symptoms of chronic myelomonocytic leukemia (CMML)
|
• beyond 5 months of age
|
• spleens mice with symptoms of chronic myelomonocytic leukemia (CMML)
• 12% of mice develop acute myeloid leukemia with a rapid increase in white blood cell count between 12 and 22 months
|
• the bone marrow of mice with symptoms of chronic myelomonocytic leukemia (CMML)
|
integument
ruffled hair
(
J:141004
)
• in mice older than 5 months
|
cellular
• beyond 5 months of age, mice exhibit immature and maturing mononuclear cells in the peripheral blood unlike wild-type mice
|
growth/size/body
• after 5 months
|
• after 5 months
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
acute myeloid leukemia | DOID:9119 |
OMIM:601626 |
J:141004 |